People · Operator

Michael Piraino

Named in public records as an officer, director or promoter · active 2017–2022 · Telecommunications, Biotechnology

2
Companies
4
Filings
$15.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
BluStream CorpTelecommunicationsSeries A$12.2M$6.3M2017
LabVoice Inc.BiotechnologySeed$3.7M$2.7M2022
Operator network

Michael Piraino at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kyle York · 8 companies · 1 sharedKyle YorkThomas Axbey · 4 companies · 1 sharedThomas AxbeyBruce Clarke · 3 companies · 1 sharedBruce ClarkeGregory Baker · 3 companies · 1 sharedGregory BakerScott Weller · 3 companies · 1 sharedScott WellerBhaskar Panigrahi · 2 companies · 1 sharedBhaskar PanigrahiKenneth Rapp · 1 companies · 1 sharedKenneth RappRobert Bean · 1 companies · 1 sharedRobert BeanThomas Folliard · 1 companies · 1 sharedThomas FolliardTim Harkness · 3 companies · 1 sharedTim HarknessFrederic Bost · 1 companies · 1 sharedFrederic BostJudy Ohm Hicks · 1 companies · 1 sharedJudy Ohm HicksJudy Ohrn Hicks · 1 companies · 1 sharedJudy Ohrn HicksMathew Hahn · 1 companies · 1 sharedMathew HahnBluStream Corp · $12.2M raisedBluStream CorpLabVoice Inc. · $3.7M raisedLabVoice Inc.Michael PirainoMP
Michael Piraino Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michael Piraino on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kyle York18
Thomas Axbey14
Gregory Baker13
Tim Harkness13
Scott Weller13
Bruce Clarke13
Bhaskar Panigrahi12
Judy Ohm Hicks11
Kenneth Rapp11
Robert Bean11
Thomas Folliard11
Frederic Bost11
Mathew Hahn11
Judy Ohrn Hicks11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.